Detalles de la búsqueda
1.
Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study.
Depress Anxiety
; 36(3): 225-234, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675739
2.
Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study.
CNS Spectr
; 23(1): 39-50, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28478771
3.
The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
Bipolar Disord
; 17(1): 63-75, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25056368
4.
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.
Paediatr Drugs
; 20(4): 353-363, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29633166
5.
Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial.
Int Clin Psychopharmacol
; 33(6): 304-311, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30044247
6.
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study.
Psychopharmacology (Berl)
; 234(2): 199-209, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27807604
7.
Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.
J Clin Psychiatry
; 76(12): e1574-82, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26717533
8.
An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial.
Schizophr Res
; 152(2-3): 450-7, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24412468
Resultados
1 -
8
de 8
1
Próxima >
>>